Web Exclusives

FDA approves new melanoma drug

The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF…

FDA publishes REMS list

Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..

AHRQ releases Spanish medication tracking tool

The Agency for Healthcare Research and Quality has released a newly revised Spanish language medication tracking tool, “Su medicamento: Infórmese. Evite riesgos.” (“Your Medicine:…

FDA approves new melanoma drug

The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have…

FDA publishes REMS list

Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..

Poll

Preferred way to get content

What is your preferred way to consume healthcare content?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.